Non-coding RNAs As Emerging Regulators and Biomarkers in Colorectal Cancer

Overview

Journal Mol Cell Biochem

Publisher Springer

Specialty Biochemistry

Date 2022 Mar 25

PMID 35332394

Authors

Chandra Kishore

Devarajan Karunagaran

Affiliations

Soon will be listed here.

Abstract

CRC is the third most common cancer occurring worldwide and the second leading cause of cancer deaths. In the year 2020, 1,931,590 new cases of CRC and 935,173 deaths were reported. The last two decades have witnessed an intensive study of noncoding RNAs and their implications in various pathological conditions including cancer. Noncoding RNAs such as miRNAs, tsRNAs, piRNAs, lncRNAs, pseudogenes, and circRNAs have emerged as promising prognostic and diagnostic biomarkers in preclinical studies of cancer. Some of these noncoding RNAs have also been shown as promising therapeutic targets for cancer treatment. In this review, we have discussed the emerging roles of various types of noncoding RNAs in CRC and their future implications in colorectal cancer management and research.

Citing Articles

Exploring the Link Between Noncoding RNAs and Glycolysis in Colorectal Cancer.

Xu L, Shen Y, Zhang C, Shi T, Sheng X J Cell Mol Med. 2025; 29(4):e70443.

PMID: 39993964 PMC: 11850098. DOI: 10.1111/jcmm.70443.

Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review).

Qiu W, Akanyibah F, Xia Y, Ocansey D, Mao F, Liang Y Int J Mol Med. 2024; 55(2).

PMID: 39704210 PMC: 11670865. DOI: 10.3892/ijmm.2024.5474.

Interplay of miRNAs and lncRNAs in STAT3 signaling pathway in colorectal cancer progression.

Farzam O, Najafi S, Amini M, Rahimi Z, Dabbaghipour R, Zohdi O Cancer Cell Int. 2024; 24(1):16.

PMID: 38185635 PMC: 10771635. DOI: 10.1186/s12935-023-03202-3.

Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.

Ponomaryova A, Rykova E, Solovyova A, Tarasova A, Kostromitsky D, Dobrodeev A Int J Mol Sci. 2023; 24(15).

PMID: 37569782 PMC: 10419249. DOI: 10.3390/ijms241512407.

The strict regulation of HIF-1α by non-coding RNAs: new insight towards proliferation, metastasis, and therapeutic resistance strategies.

Jawad S, Altalbawy F, Hussein R, Fadhil A, Abed Jawad M, Zabibah R Cancer Metastasis Rev. 2023; 43(1):5-27.

PMID: 37552389 DOI: 10.1007/s10555-023-10129-8.

References

Arnold M, Sierra M, Laversanne M, Soerjomataram I, Jemal A, Bray F . Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2016; 66(4):683-691. DOI: 10.1136/gutjnl-2015-310912. View

Arnold M, Soerjomataram I, Ferlay J, Forman D . Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 2014; 64(3):381-7. DOI: 10.1136/gutjnl-2014-308124. View

Schatoff E, Leach B, Dow L . Wnt Signaling and Colorectal Cancer. Curr Colorectal Cancer Rep. 2017; 13(2):101-110. PMC: 5391049. DOI: 10.1007/s11888-017-0354-9. View

Loboda A, Nebozhyn M, Watters J, Buser C, Shaw P, Huang P . EMT is the dominant program in human colon cancer. BMC Med Genomics. 2011; 4:9. PMC: 3032646. DOI: 10.1186/1755-8794-4-9. View

Kishore C, Sundaram S, Karunagaran D . Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells. Chem Biol Interact. 2019; 309:108725. DOI: 10.1016/j.cbi.2019.108725. View

Kishore C, Bhadra P . Current advancements and future perspectives of immunotherapy in colorectal cancer research. Eur J Pharmacol. 2020; 893:173819. DOI: 10.1016/j.ejphar.2020.173819. View

Deng X, Su R, Weng H, Huang H, Li Z, Chen J . RNA N-methyladenosine modification in cancers: current status and perspectives. Cell Res. 2018; 28(5):507-517. PMC: 5951805. DOI: 10.1038/s41422-018-0034-6. View

Esteller M . Non-coding RNAs in human disease. Nat Rev Genet. 2011; 12(12):861-74. DOI: 10.1038/nrg3074. View

Slack F, Chinnaiyan A . The Role of Non-coding RNAs in Oncology. Cell. 2019; 179(5):1033-1055. PMC: 7347159. DOI: 10.1016/j.cell.2019.10.017. View

10.

Macfarlane L, Murphy P . MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2011; 11(7):537-61. PMC: 3048316. DOI: 10.2174/138920210793175895. View

11.

Ambros V . The functions of animal microRNAs. Nature. 2004; 431(7006):350-5. DOI: 10.1038/nature02871. View

12.

Yu X, Xie Y, Zhang S, Song X, Xiao B, Yan Z . tRNA-derived fragments: Mechanisms underlying their regulation of gene expression and potential applications as therapeutic targets in cancers and virus infections. Theranostics. 2021; 11(1):461-469. PMC: 7681095. DOI: 10.7150/thno.51963. View

13.

Yu M, Lu B, Zhang J, Ding J, Liu P, Lu Y . tRNA-derived RNA fragments in cancer: current status and future perspectives. J Hematol Oncol. 2020; 13(1):121. PMC: 7487644. DOI: 10.1186/s13045-020-00955-6. View

14.

Huang Y, Bai J, Ren H . PiRNAs biogenesis and its functions. Bioorg Khim. 2015; 40(3):320-6. View

15.

Fang Y, Fullwood M . Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer. Genomics Proteomics Bioinformatics. 2016; 14(1):42-54. PMC: 4792843. DOI: 10.1016/j.gpb.2015.09.006. View

16.

Xiao-Jie L, Ai-Mei G, Li-Juan J, Jiang X . Pseudogene in cancer: real functions and promising signature. J Med Genet. 2014; 52(1):17-24. DOI: 10.1136/jmedgenet-2014-102785. View

17.

Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P . CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017; 16(1):94. PMC: 5440908. DOI: 10.1186/s12943-017-0663-2. View

18.

Cui B, Chen L, Zhang S, Mraz M, Fecteau J, Yu J . MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia. Blood. 2014; 124(4):546-54. PMC: 4110661. DOI: 10.1182/blood-2014-03-559690. View

19.

Liu K, Du J, Ruan L . MicroRNA-21 regulates the viability and apoptosis of diffuse large B-cell lymphoma cells by upregulating B cell lymphoma-2. Exp Ther Med. 2017; 14(5):4489-4496. PMC: 5647720. DOI: 10.3892/etm.2017.5021. View

20.

Gabriely G, Yi M, Narayan R, Niers J, Wurdinger T, Imitola J . Human glioma growth is controlled by microRNA-10b. Cancer Res. 2011; 71(10):3563-72. PMC: 3096675. DOI: 10.1158/0008-5472.CAN-10-3568. View